Viraemia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy https://www.medrxiv.org/content/10.1101/2023.06.16.23291523
Viraemia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy https://www.medrxiv.org/content/10.1101/2023.06.16.23291523